ILMN Illumina: Prakiraan wutah bathi kanggo taun ngarep

Lambang korporat lan logo Illumina, Inc. (ILMN)

Illumina, Inc. (ILMN) maintains global priority in the NGS field, remaining resilient following its spin-off from Grail. This monopoly is sustained by a rigorous patent barrier and a closed ecosystem that prevents equipment switching. A "razor-and-blade" model ensures a steady cash flow from recurring reagent sales. The projected net profit growth rate for n+1 visualizes these expectations, where the parameter value equals 13.60.

Illumina Corp (ILMN): Prakiraan wutah bathi resik saben saham kanggo taun ngarep saka 04.07.2022 nganti 17.11.2026

Rincian analitis lan laporan data perusahaan Illumina Inc (ILMN)

- rega lan prakiraan konsensus rega:
Analisis komprehensif perusahaan:illumina.com, ILMN
Produk merek Illumina

Conservative capital requires high transparency of projected cash flows to ensure portfolio stability. This indicator measures analyst consensus expectations for net earnings per share growth rates in the coming year. For Illumina, Inc. (ILMN), this calculation is critical during the transition from limited scientific budgets to the high-margin oncology diagnostics market. By analyzing forward EPS dynamics, an investor determines the timing of a market trend reversal.

Analisis pesaing

A (agilent.com) - Prakiraan wutah bathi kanggo taun ngarep|DGX - Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep EXAS|RVTY (Revvity) - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep bio-rad.com BIO|NNNN: Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep|Sotera Health Corp - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep QuidelOrtho QDEL|OPK (OPKO Health) - Prakiraan wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep CareDx, Inc. (CDNA)|Prakiraan wutah bathi saben saham kanggo taun ngarep MRVI|Prakiraan wutah bathi resik saben saham ing taun ngarep Fulgent FLGT|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Standard BioTools Inc. (LAB)|CTKB (Cytek Biosciences, Inc.) - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep OSUR (OraSure Corp)|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Exagen Inc. (XGN)|MDXH: Prakiraan wutah bathi saben saham kanggo taun ngarep|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Lucid Diagnostics Inc LUCD|PRE (Prenetics Global Ltd) - Prakiraan wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi saben saham kanggo taun ngarep Insight Molecular|TRIB (Trinity Biotech) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep PRPH|Prakiraan wutah bathi kanggo taun ngarep AIMD|Proyeksi tambahing bathi saben saham ing taun ngarep CODX|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Heart Test Laboratories HSCS|BMRA: Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep|CDIO - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Onconetix Corp (ONCO) - Prakiraan wutah bathi saben saham kanggo taun ngarep|VRAX (Virax Biolabs Group Ltd) - Prakiraan wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Bluejay Diagnostics Corp (BJDX)|AWH (Aspira Women's Health, Inc.) - Prakiraan wutah bathi kanggo taun ngarep|AXDX - Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep centogene.com (CNTG)|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Enzo Biochem|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep FRES|Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep GTG Labs|23andMe Holding Co - Prakiraan wutah bathi kanggo taun ngarep|PMD - Prakiraan wutah bathi kanggo taun ngarep